Biohaven Email Format

Biotechnology ResearchConnecticut, United States201-500 Employees

Biohaven is a mid-sized biotechnology research company based in New Haven, Connecticut. It concentrates on developing novel therapies intended to address unmet patient needs through scientific innovation and a patient-first culture. The organization relies on an agile, resilient team that seeks to challenge conventional approaches to advance life-changing treatments.

Its pipeline includes protein-degrader programs for autoimmune diseases, with BHV-1300 targeting Graves’ disease and BHV-1400 for IgA nephropathy, and pivotal studies planned for mid-2026 following encouraging early biomarker data. The company is also advancing an oral PKM2 modulator, BHV-8100, with first-in-human dosing reported, and pursuing epilepsy programs such as opakalim that aim to improve seizure control.

Sign up for free to view info

Company overview Employee directory